INTRODUCTION
============

Rab GTPases are nucleotide-dependent switches that serve as master regulators of membrane traffic ([@B16]). Each Rab recruits a specific set of effectors that, in turn, directs different steps of a vesicular transport reaction. Because effectors, by definition, bind preferentially to the GTP-bound form of a Rab, guanine nucleotide exchange factors (GEFs) that catalyze the displacement of GDP from the Rab and thereby promote binding of GTP are essential for Rab function. Controlling when and where a GEF is active will therefore define the temporal and spatial regulation of its substrate Rab and downstream effectors.

We focus here on the final stage of the secretory pathway in the budding yeast *Saccharomyces cerevisiae*. Secretory vesicles derived from the late Golgi are delivered to sites of polarized cell surface growth, such as the tip of small buds or the neck of large-budded cells, by the type V myosin Myo2p. They are then tethered to the cell cortex at these sites by the octomeric exocyst complex and finally fuse with the plasma membrane through the formation of a *trans*--soluble *N*-ethylmaleimide--sensitive factor attachment protein receptor (SNARE) complex. The Rab GTPase Sec4p controls these three steps through direct interactions of Sec4p-GTP with Myo2p, the exocyst subunit, Sec15p, and the SNARE regulator Sro7p ([@B14]; [@B13]; [@B17]).

Activation of Sec4p requires the function of Sec2p, a highly efficient and specific Sec4p GEF ([@B41]). The N-terminus of Sec2p (amino acids \[aa\] 1--160) forms a homodimeric coiled-coil structure that catalyzes the nucleotide exchange reaction on Sec4p, whereas the remainder of Sec2p (aa 160--759) interacts with several different ligands that together determine its subcellular localization. Both Sec4p and Sec2p are highly concentrated on the surface of secretory vesicles yet exhibit no detectable association with the Golgi membranes from which these vesicles originate. The recruitment of Sec2p to secretory vesicles requires two different signals working in concert. One signal is the upstream, late Golgi--associated Rab Ypt32p ([@B30]; [@B25]). The region of Sec2p covering aa 160 to 258 binds to the GTP-bound form of Ypt32p, and this interaction is essential for Sec2p localization. We termed this recruitment mechanism a Rab GEF cascade, and there are now several analogous examples in which a GEF for one Rab is recruited by the GTP-bound form of the preceding Rab on a membrane traffic pathway (reviewed in [@B27]). Sec2p localization also requires the Golgi-associated pool of phosphatidylinositol-4-phosphate (PI(4)P) ([@B26]). This phosphoinositide binds to several polybasic patches within a region of Sec2p downstream of the Ypt32p binding site. Mutation of those polybasic sites or loss of function of the Golgi-associated phosphatidylinositol 4-kinase Pik1p blocks Sec2p recruitment to secretory vesicles.

In addition to binding to Ypt32p-GTP and PI(4)P, Sec2p also interacts with the Sec4p effector Sec15p ([@B25]). The interaction of a GEF with an effector of its substrate Rab may promote a positive feedback loop in which the GEF activates the Rab and the Rab recruits the effector, which in turn helps to recruit more of the GEF. A GEF--effector interaction could thereby lead to the formation of a metastable membrane domain marked by high concentrations of the activated Rab, its GEF, and its effector. Of importance, Sec15p binds to the same region of Sec2p that binds to Ypt32p-GTP, and the two ligands compete against one another for binding to Sec2p.

We found that the interaction of Sec2p with its two competing binding partners, Ypt32p-GTP and Sec15p, can be regulated in several ways. Increased levels of PI(4)P inhibit the binding of Sec2p to Sec15p and thus promote binding to Ypt32p-GTP ([@B26]). This may be the situation on newly formed secretory vesicles, which have a high concentration of PI(4)P. However, by the time these vesicles have been delivered to sites of polarized surface growth, the PI(4)P levels are reduced through the action of the Osh4p protein, allowing Sec15p to displace Ypt32p on Sec2p ([@B20]). Phosphorylation also plays a key role in regulating the choice of binding partner. Sec2p is highly phosphorylated under normal growth conditions ([@B9]) and the phosphorylation of a patch of serines within the shared Ypt32p/Sec15p binding site promotes binding of Sec2p to Sec15p and inhibits binding to Ypt32p-GTP ([@B35]).

Striking parallels exist between the phosphoregulation of Sec2p and Rabin8, its mammalian homologue. It was reported that the phosphorylation of Rabin8 is directed by the kinase NDR1/2 and promotes binding to Sec15p ([@B39]; [@B6]). Nonetheless, there is no consensus site (HxRxxS/T) for a yeast NDR homologue such as Cbk1 near the phosphorylated serine patch within the Ypt32p/Sec15p binding region of Sec2p (compared with Rabin8), even though it was demonstrated that Cbk1 binds to and phosphorylates Sec2p in vitro ([@B18]). Another study showed that, in *Candida albicans*, Sec2p is phosphorylated by the cyclin-dependent kinase Cdc28p ([@B3]). However, this kinase targets Sec2p in its C-terminal region, well downstream of the Ypt32p/Sec15p binding site. Thus it appears likely that the kinase controlling the interactions of Sec2p with Ypt32p and Sec15p in *S. cerevisiae* is neither Cbk1p nor Cdc28p. For this reason, we systematically screened for a kinase that phosphorylates Sec2p within this key regulatory region.

RESULTS
=======

The redundant casein kinases Yck1p and Yck2p phosphorylate Sec2p in vivo
------------------------------------------------------------------------

To identify the kinases(s) responsible for Sec2p phosphorylation, we performed a directed genetic screen using kinase deletion strains selected from the yeast deletion library. We observed previously that Sec2p phosphorylation leads to a slightly reduced mobility of Sec2p on SDS--PAGE gels ([@B35]). To improve the detection of a phosphorylation-dependent mobility shift of Sec2p and focus on phosphorylation of sites within the Ypt32p/Sec15p binding region, we overexpressed a truncated Sec2p protein, Sec2p 1-508, on a CEN vector in various kinase deletion strains. This allele is efficiently phosphorylated in vivo ([@B9]), interacts with all known Sec2p binding partners ([@B25]; [@B26]), and functions well as the sole copy of this essential gene ([@B9]). We observed that in lysates of yeast deleted for either *YCK1* or *YCK2* but not *YCK3*, Sec2 1-508 splits into two bands, one of which has increased mobility relative to the band in the control strain ([Figure 1A](#F1){ref-type="fig"}). To confirm that the difference in migration of the two bands is due to a difference in Sec2p phosphorylation, we purified glutathione *S*-transferase (GST)--tagged Sec2p 1-508 overexpressed from a CEN plasmid vector in wild-type (WT) and *yck1Δ*, *yck2Δ*, and *yck3Δ* mutants and treated the isolated Sec2p preparations with calf intestinal alkaline phosphatase (CIP). We then analyzed the mobility of Sec2p by SDS--PAGE ([Figure 1B](#F1){ref-type="fig"}). After CIP treatment, the top Sec2p band from WT and *yck3Δ* strains, which is lacking in the *yck1Δ* and *yck2Δ* mutants, disappears. Note that during the purification procedure, Sec2p from WT cells was partially dephosphorylated and appeared as a double band rather than the single upper band, as observed in [Figure 1A](#F1){ref-type="fig"}. These observations support the proposal that Sec2p is only partially phosphorylated in *yck1Δ* and *yck2Δ* mutants. To extend these findings, we analyzed the mobility of GST-tagged Sec2p 1-508 protein from a lysate of a strain deleted for the *YCK1* gene and expressing only a thermosensitive allele of *YCK2* (*yck-ts* mutant; [@B34]). We observed that in the *yck-ts* mutant, after incubation of cells at either 25 or 37°C, Sec2p appears to be almost entirely dephosphorylated ([Figure 1C](#F1){ref-type="fig"}). To verify that Yck1p and Yck2p are also responsible for the phosphorylation of the full-length Sec2p protein (Sec2p FL), we purified GST-tagged Sec2p FL from the control strain and the *yck-ts* mutant and treated the protein with the CIP phosphatase in the presence or absence of EDTA (a known inhibitor of CIP; [Figure 1D](#F1){ref-type="fig"}). In the control strain, Sec2p FL exhibits a smear extending from the top of the major Sec2p band. This extension disappears after CIP treatment and yet is preserved in presence of the phosphatase inhibitor EDTA. However, in the *yck-ts* strain, Sec2p FL always appears without an extension in its nonphosphorylated form. Taken together, these findings strongly support the hypothesis that the redundant Yck1p and Yck2p kinases phosphorylate Sec2p in vivo.

![The casein kinases Yck1p and Yck2p phosphorylate Sec2p in vivo and target phosphosites within the Sec15p/Ypt32p binding region. (A) Control yeast cells or cells deleted for *YCK3*, *YCK1*, or *YCK2* genes and overexpressing Sec2p 1-508 on a CEN vector (NY3099, NY3100, NY3101, and NY3102, respectively) were grown overnight at 25°C and quickly lysed by NaOH treatment. The mobility of Sec2p 1-508 protein was visualized after SDS--PAGE gel with anti-Sec2p antibody. (B) GST--Sec2p 1-508 protein, overexpressed on a CEN vector in control yeast cells or cells deleted for *YCK3*, *YCK1*, or *YCK2* genes (NY3103, NY3104, NY3105, and NY3106, respectively), was purified, treated or not with the phosphatase CIP, and visualized after SDS--PAGE with anti-Sec2p antibody. (C) Control yeast cells, deleted for *YCK1*, expressing *yck2-1* or the *yck-ts* mutant, all overexpressing GST--Sec2p 1-508 on a CEN vector (NY3111, NY3112, NY3113, and NY3114, respectively), were grown overnight at 25°C and then shifted to 37°C for 2 h. The mobility of GST--Sec2p 1-508 protein was analyzed as in A. (D) Control yeast strain or the *yck-ts* mutant, overexpressing GST--Sec2p full length (FL) on a CEN vector (NY3115 and NY3118, respectively), were grown overnight at 25°C and then shifted to 37°C for 1 h. GST--Sec2p FL protein was purified, treated or not with the phosphatase CIP ± EDTA and visualized after SDS--PAGE by Coomassie brilliant blue staining. (E) Top, control yeast strain or the *yck-ts* mutant, overexpressing GST--Sec2p FL WT, S181-8A, or S181-8D/E on a CEN vector (NY3115, NY3118, NY3116, NY3119, NY3117, and NY3120), were grown overnight at 25°C and then shifted to 37°C for 1 h. GST Sec2p FL protein was purified and visualized after SDS--PAGE by Coomassie brilliant blue staining. Bottom, control yeast strain or the *yck-ts* mutant, overexpressing GST--Sec2p 1-508 WT, S181-8A, or S181-8D/E on a CEN vector (NY3111, NY3114, NY3121, NY3123, NY3122, and NY3124), were grown overnight at 25°C and quickly lysed by NaOH treatment. The mobility of Sec2p 1-508 protein was visualized after SDS--PAGE with anti-Sec2p antibody. (F) The Sec2p--Sec15p interaction is impaired in the *yck-ts* mutant. Sec2p-3xGFP was immunoprecipitated with GFP antibody in the control yeast strain or in the *yck-ts* mutant coexpressing Sec15p-13xmyc (NY3136 and NY3137, respectively). Yeast strains expressing untagged Sec2p (NY3134 and NY3135) were used as negative control. Coprecipitated Sec15p-13xmyc and the amount of Sec15p-13xmyc in 0.05% of lysates were detected with anti-myc antibody. The intensity of the bands was quantified using ImageJ (National Institutes of Health, Bethesda, MD). The percentage of Sec15p bound to Sec2p was calculated and indicated. Mean and SD of three different experiments. \**p* \< 0.03; Student's *t* test.](686fig1){#F1}

Yck1p and Yck2p target phosphosites within the Sec15p/Ypt32p binding region
---------------------------------------------------------------------------

Next we explored whether Yck1p and Yck2p target the phosphosites within the Sec15p/Ypt32p binding region that we had identified previously (aa 181--188; [@B35]). We analyzed the mobility shift of the nonphosphorylatable (S181-8A) and phosphomimetic (S181-8D/E) alleles within the context of either GST-tagged Sec2p FL or 1-508 protein overexpressed in the control strain or the *yck-ts* mutant ([Figure 1E](#F1){ref-type="fig"}). Sec2p FL mobility was analyzed after purification on glutathione beads, whereas Sec2p 1-508 was analyzed directly from a yeast lysate. Mutation of the 181-188 phosphosites to A or D/E greatly reduced the difference in mobility of Sec2p FL or Sec2p 1-508 observed in the *yck-ts* strain relative to the WT strain. This result implies that Yck1p and Yck2p target the phosphosites between residues 181 and 188. The residual Yck1p/2p-dependent band shift of Sec2p FL observed with the 181--188 phosphosite mutants suggests that Yck1p/2p might also target another site in Sec2p. This residual band shift is not apparent using the Sec2p 1-508 construct, suggesting that this phosphosite resides downstream of residue 508.

Phosphomutations in Sec15p/Ypt32p binding region do not affect Sec2p GEF activity
---------------------------------------------------------------------------------

Next we investigated whether phosphorylation within the Sec15p/Ypt32p binding region of Sec2p affects its ability to catalyze nucleotide exchange. The exchange activity of wild-type Sec2p and the nonphosphorylatable or phosphomimetic mutant (Sec2p S181-8A or D/E, respectively) was measured in vitro. Full-length GST-tagged Sec2p and the phosphosite mutants were purified from bacteria, as was full-length hexahistidine (His~6~)-tagged Sec4p. Sec4p was preloaded with GDP, and then the fluorescence resonance energy transfer (FRET) signal between Sec4p tryptophans and a mant derivative of GTP was followed over time (Supplemental Figure S1). We observed that the nonphosphorylatable Sec2p (S181-8A), as well as the phosphomimetic Sec2p (S181-8D/E), stimulated nucleotide exchange on Sec4p to a similar extent as wild-type Sec2p. This result is in line with the fact that residues 181--188 are located downstream of the catalytic coiled-coil domain (residues 1--160) of Sec2p.

The Sec2p--Sec15p interaction is impaired in the *yck-ts* mutant
----------------------------------------------------------------

Because Yck1p and Yck2p target phosphosites within the Ypt32p/Sec15p binding region, we determined whether the interaction of Sec2p with Sec15p is affected in the *yck-ts* mutant. We assessed the efficiency of coprecipitation of Sec15p-13xmyc with Sec2p-3x green fluorescent protein (GFP) from lysates of yeast expressing at endogenous levels the tagged alleles as the sole copy of each gene. After a 1-h shift of yeast cells to 37°C, Sec2p-3xGFP was immunoprecipitated with anti-GFP antibody from total lysates. Immunoprecipitates were then probed with anti-myc antibody to detect Sec15p ([Figure 1F](#F1){ref-type="fig"}). We observed a significant threefold decrease in Sec15p--13xmyc coprecipitation in the *yck-ts* strain. We observed a similar but not statistically significant reduction when cells were incubated at 25°C rather than 37°C. These results establish that phosphorylation of Sec2p by Yck1p and Yck2p promotes the interaction of Sec2p with Sec15p.

Sec2p localization is modestly affected in a sensitized background when *YCK2* is deleted
-----------------------------------------------------------------------------------------

We showed previously that locking Sec2p in either its phosphorylated or unphosphorylated state affects its localization in a sensitized background (*ypt31Δ-ypt32^A141D^*; [@B35]). Therefore we analyzed Sec2p localization in various strains in which Yck1p and/or Yck2p are affected. In the control strain, Sec2p-3xGFP concentrates at the bud tips of small- and medium-budded cells and at the neck between the mother and bud of large-budded cells (Supplemental Figure S2A). Sec2p localization was not significantly affected in the *yck-ts* mutant either at 25°C or after a 90-min incubation at 37°C. After 90 min at 37°C, *yck-ts* mutant cells start to form elongated buds, as previously described ([@B34]). Next we analyzed Sec2p-3xGFP localization in the *ypt31Δ-ypt32^A141D^*-sensitized background (Supplemental Figure S2B). In agreement with our prior study, in this background, the polarized localization of Sec2p-3xGFP is already affected relative to the wild-type control (compare Supplemental Figure S2, A, left, with B). However, the phenotype becomes modestly but significantly more severe when the *YCK2* gene is deleted. This result supports the idea that phosphorylation of Sec2p by Yck2p contributes to Sec2p localization, possibly by promoting a switch from binding Ypt32p-GTP to binding to Sec15p.

Sec15p and Ypt32p are not significantly mislocalized in the *yck-ts* mutant
---------------------------------------------------------------------------

Yck1p/Yck2p proteins are most similar at a structural level to the casein kinase 1γ (CK1γ) ([@B40]), and, accordingly, it was observed that CK1γ1 and CK1γ3 are able to complement the defects of the *yck-ts* mutant ([@B44]). Because it was reported that the *Drosophila* CK1γ homologue, gilgamesh, is important for the localization of Sec15 and Rab11 (the mammalian homologue of Ypt31p/Ypt32p; [@B12]), we analyzed the localization of Sec15p-3xGFP and GFP-Ypt32p in the *yck-ts* strain. However, neither Sec15p nor Ypt32p appears to be significantly mislocalized in the mutant strain at the permissive temperature or after incubation of the cells at 37°C (Supplemental Figure S2, C and D, respectively).

Yck2p binds to the autoinhibitory region of Sec2p
-------------------------------------------------

Next we tested whether Yck2p is able to interact with Sec2p in vitro. Initially, we performed binding assays with N-terminally GST-tagged Sec2p and N-terminally His~6~-tagged Yck2p, both expressed and purified from bacteria, but observed no detectable interaction. We considered the possibility that Yck2p might not fold efficiently in bacteria. Therefore we incubated recombinant GST-tagged Sec2p with a lysate of yeast overexpressing N-terminally GFP-tagged Yck2p. By this approach, a weak but specific interaction was detected between Yck2p and Sec2p ([Figure 2B](#F2){ref-type="fig"}). Note that GFP-tagged Yck2p appears in two bands of differing molecular weights and that Sec2p preferentially binds to the upper band.

![The casein kinase Yck2p binds to the autoinhibitory region of Sec2p and phosphorylates Sec2p in vitro. (A) Top, domain organization of Sec2p. The N-terminal region contains a coiled-coil domain (CC), which catalyzes the exchange of GDP for GTP on Sec4p. Downstream are overlapping binding sites for Sec15p and Ypt32p-GTP, which compete against each other to bind to Sec2p. The choice of Sec2p between these two binding partners is, in part, regulated by phosphorylation of the phosphoregion at aa 181--188. Three positively charged patches allow Sec2p to interact with the phosphoinositide PI(4)P. Finally, the region of aa 450--508, named the autoinhibitory region, negatively regulates Sec15p binding to Sec2p by an autoinhibitory mechanism. Bottom, in vivo phosphorylation results of different Sec2p constructs ([@B9]). (B) Yck2p binds to the autoinhibitory region of Sec2p. Yeast lysate overexpressing GFP-Yck2p (NY3138) was incubated with different GST-Sec2p constructs purified from bacteria and immobilized on glutathione beads. Bound GFP-Yck2p protein was detected with anti-GFP antibody. Because GST--Sec2p 1-508 protein runs at the same molecular weight as GFP-Yck2p (which explains the distortion of the GFP signal), we checked that the GFP signal is specific to GFP-Yck2p and does not cross-react with GST--Sec2p 1-508. GST-Sec2p was detected with anti-GST antibody. The intensity of the bands was quantified using ImageJ. The percentage of Yck2p bound to Sec2p was calculated and is indicated on a logarithmic scale. Mean and SD of at least three different experiments. \**p* \< 0.002; Student's *t* test. The increase observed for GST--Sec2p 1-508 is not significantly different from GST--Sec2p wild type. (C) Yck2p phosphorylates Sec2p in vitro. GFP-Yck2p wild type or H187Y was immunoprecipitated from a yeast lysate with protein A/G beads (NY3138 or NY3139, respectively) and incubated with bacterial eluted GST--Sec2p 1-508 wild type or S181-8A protein. GST--Sec2p 1-508 was detected with anti-GST antibody, and the phosphorylated form is characterized by an additional band above the major Sec2p band (indicated with an asterisk). GFP-Yck2p protein was detected with anti-GFP antibody.](686fig2){#F2}

In a prior study, we observed that the region from amino acids 450 to 508, called the autoinhibitory region, is required for Sec2p phosphorylation in vivo ([Figure 2A](#F2){ref-type="fig"}; [@B9]). Therefore we explored the possibility that Yck2p binds to this region. We performed binding assays of GFP-tagged Yck2p with different truncated GST-tagged Sec2p proteins. As shown in [Figure 2B](#F2){ref-type="fig"}, Yck2p binds well to Sec2p 1-508, but the interaction with Sec2p 1-450 is almost sevenfold reduced in comparison to wild-type Sec2p. No interaction was detected with Sec2p 1-160 or GST alone. These findings indicate that the interaction of Yck2p with Sec2p requires the autoinhibitory region (aa 450--508) and are in complete agreement with our prior in vivo phosphorylation studies. Taken together, the findings support a model in which Yck2p binds to the region of Sec2p between residues 450 and 508 but then phosphorylates sites between residues 181 and 188.

Yck2p phosphorylates Sec2p in vitro
-----------------------------------

To determine whether Yck2p is able to phosphorylate Sec2p in vitro, we immunoprecipitated GFP-tagged Yck2p from a yeast lysate and incubated it with recombinant GST-tagged Sec2p 1-508 protein. We observed that in presence of wild-type Yck2p and ATP, Sec2p shifts to a higher apparent molecular weight relative to control reactions without ATP or with a dead kinase allele, Yck2p H187Y (described in [@B34]; [Figure 2C](#F2){ref-type="fig"}). Note that the Yck2p protein appears to undergo autophosphorylation after addition of ATP. This result shows that wild-type but not kinase-dead Yck2p is able to phosphorylate Sec2p in vitro. We also observed that the S181-8A allele of Sec2p 1-508 protein undergoes less of a mobility shift upon incubation with Yck2p, supporting the hypothesis that Yck2p targets predominantly the phosphosites within the Ypt32p/Sec15p binding region.

Sec2p phosphorylation by Yck2p is inhibited by the phosphoinositide PI(4)P
--------------------------------------------------------------------------

We showed previously that Sec2p binds directly to the phosphoinositide PI(4)P ([@B26]). This interaction is crucial for the recruitment of Sec2p to Golgi-derived secretory vesicles and also serves to inhibit the association of Sec2p with Sec15p. We identified three positively charged patches within Sec2p that are responsible for PI(4)P binding. These patches lie just upstream and within the autoinhibitory region between residues 450 and 508 ([Figure 2A](#F2){ref-type="fig"}). Because Yck2p binds to Sec2p near these PI(4)P binding patches, we investigated whether PI(4)P has any effect on the phosphorylation of Sec2p by Yck2p. We immunoprecipitated GFP-tagged Yck2p from a yeast lysate and incubated it with recombinant GST-tagged Sec2p 1-508 protein in the presence or absence of liposomes containing different amounts of PI(4)P. We showed previously that the truncated Sec2p 1-508 protein is able to interact with the phosphoinositide ([@B26]). We observed a dose-dependent inhibition of Sec2p phosphorylation with increasing concentration of PI(4)P ([Figure 3A](#F3){ref-type="fig"}). PI(4)P has no apparent effect on Yck2p activity per se, as Yck2p autophosphorylation was unaffected by increasing amounts of PI(4)P in the reaction. These results strongly suggest that the interaction of Sec2p with PI(4)P inhibits its phosphorylation by Yck2p.

![Modulation of Sec2p phosphorylation. (A) Sec2p in vitro phosphorylation by Yck2p is inhibited by the phosphoinositide PI(4)P. GFP-Yck2p was immunoprecipitated from a yeast lysate with protein A/G beads (NY3138) and incubated with bacterial eluted GST--Sec2p 1-508 and with or without ATP and liposomes containing different amounts of PI(4)P (liposomes 1--4, which contain, respectively, 0, 2, 5, and 10% PI(4)P). GST--Sec2p 1-508 was detected with anti-GST antibody, and the phosphorylated form is indicated with an arrow. GFP-Yck2p protein was detected with anti-GFP antibody. The intensity of the phosphorylated form of GST--Sec2p 1-508 was quantified using ImageJ and normalized and is indicated. Mean and SD of three different experiments. \**p* \< 0.03, \*\**p* \< 0.004; Student's *t* test relative to the condition "+ATP" (lane 2). (B) Sec2p phosphorylation is affected in Pik1p and Sac1p mutants. Control yeast cells (NY3125 and NY3103), deleted for *OSH4* (NY3132) or *SAC1* (NY3164) genes or the *pik1-101* mutant (NY3133), all overexpressing GST--Sec2p 1-508 on a CEN vector (with LEU or HIS selection), were grown overnight at 25°C and quickly lysed by NaOH treatment. The mobility of GST--Sec2p 1-508 protein was visualized after SDS--PAGE with anti-Sec2p antibody. (C) Sec2p phosphorylation may be linked to the vesicle cycle. Control yeast cells (NY3125) or *ypt31Δ-ypt32^A141D^* (NY3126), *sec4-8* (NY3127), *sec15-1* (NY3128), *sec6-4* (NY3129), and *sec1-1* (NY3130) mutants, all overexpressing GST--Sec2p 1-508 on a CEN vector, were grown overnight at 25°C and shifted for 1 h at 37°C. Yeast cells were quickly lysed by NaOH treatment, and the mobility of GST--Sec2p 1-508 protein was visualized after SDS--PAGE with anti-Sec2p antibody. (D) Sec2p phosphorylation is stimulated in presence of glucose. Control yeast cells or cells deleted for the *YCK2* or *YCK1* genes and overexpressing Sec2p 1-508 on a CEN vector (NY3099, NY3102, and NY3101, respectively) were grown overnight at 25°C in a YP medium containing 2% raffinose and shifted for 1 h in 2% glucose. The cells were quickly lysed by NaOH treatment, and the mobility of Sec2p 1-508 protein was visualized after SDS--PAGE with anti-Sec2p antibody.](686fig3){#F3}

Sec2p phosphorylation is affected in Pik1p and Sac1p mutants
------------------------------------------------------------

We next investigated Sec2p phosphorylation in several yeast strains that affect the synthesis, turnover, or intracellular distribution of PI(4)P. We reported previously that in the *pik1-101* mutant (a thermosensitive allele of Pik1p), where the Golgi pool of PI(4)P is greatly reduced ([@B2]), Sec2p is no longer recruited to secretory vesicles ([@B26]). In addition, in a strain deleted for *OSH4* (*osh4Δ*), we observed an accumulation of PI(4)P on secretory vesicles ([@B20]). Finally, in a strain deleted for *SAC1 (sac1Δ)*, coding for a primarily endoplasmic reticulum (ER)--associated PI(4)P phosphatase, a general increase in PI(4)P level was reported ([@B37]). Therefore we analyzed the mobility of GST-tagged Sec2p 1-508 from *pik1-101, osh4Δ*, and *sac1Δ* mutants. We observed reduced phosphorylation of Sec2p in *pik1-101* and *sac1Δ* lysates, whereas Sec2p phosphorylation was not significantly affected in *osh4Δ* lysates ([Figure 3B](#F3){ref-type="fig"}). One interpretation of these results is that Sec2p must be recruited to secretory vesicles to be phosphorylated. This is consistent with the observation that Yck1p and Yck2p are lipid-modified kinases that ride on secretory vesicles to reach the plasma membrane ([@B1]). Results shown in [Figure 3A](#F3){ref-type="fig"} predict that after Sec2p recruitment, the high level of PI(4)P on immature secretory vesicles would prevent Sec2p phosphorylation by Yck1p/Yck2p until the level of PI(4)P is reduced through the action of Osh4p. We were not able to detect a significant decrease in Sec2p phosphorylation in the *osh4Δ* strain relative to wild type. Perhaps the PI(4)P on secretory vesicles in *osh4Δ* cells does not reach the level needed to strongly inhibit Sec2p phosphorylation. However, loss of Sac1p leads to a much larger increase in PI(4)P levels, and Sec2p phosphorylation was greatly reduced in this mutant.

Sec2p phosphorylation may be linked to vesicle cycle
----------------------------------------------------

In our previous study, we proposed that Sec2p undergoes a phosphorylation--dephosphorylation cycle that is coupled to vesicular traffic ([@B35]). By this proposal, Sec2p phosphorylation would begin once the level of PI(4)P decreases on the secretory vesicle, and dephosphorylation would occur before vesicle fusion with the plasma membrane (see later discussion of [Figure 5](#F5){ref-type="fig"}). Therefore we analyzed the mobility of GST-tagged Sec2p 1-508 from yeast lysates expressing thermosensitive alleles of various components involved in the late stages of the secretory pathway. [Figure 3C](#F3){ref-type="fig"} shows that, in mutants affected at an early step of the post-Golgi secretory pathway (*ypt31Δ-ypt32^A141D^*, *sec4-8*, and *sec15-1* strains), Sec2p is predominantly unphosphorylated, as in *pik1-101*, after growth of yeast cells overnight at 25°C. We were not able to observe any difference after incubation of cells at 37°C, which stimulates phosphorylation and might thereby mask the differences in Sec2p phosphorylation. In contrast, in mutants affected in the final steps of the secretory pathway, such as *sec6-4*, defective at the tethering step, and *sec1-1*, at the fusion step ([@B8]), Sec2p is hyperphosphorylated after incubation of cells at 37°C. This supports the hypothesis that the Sec2p phosphocycle is linked to the vesicle cycle.

Sec2p phosphorylation is stimulated in the presence of glucose
--------------------------------------------------------------

Several studies implicated Yck1p and Yck2p in glucose sensing ([@B10]; [@B29]; [@B11]). To investigate whether Sec2p phosphorylation is modulated by glucose level, we analyzed Sec2p mobility shift by SDS--PAGE of yeast lysates overexpressing Sec2p 1-508 after overnight incubation in a medium containing 2% raffinose or after 1-h shift to 2% glucose ([Figure 3D](#F3){ref-type="fig"}). In 2% glucose, as shown in [Figure 1A](#F1){ref-type="fig"}, Sec2p 1-508 is predominantly phosphorylated in a wild-type strain and half phosphorylated/half dephosphorylated in *yck1Δ* and *yck2Δ* mutants. However, we observed that the incubation of yeast cells in 2% raffinose leads to a shift toward the dephosphorylated form of Sec2p. These findings indicate that glucose promotes Sec2p phosphorylation.

Yck1p and Yck2p are important for efficient secretion
-----------------------------------------------------

The Robinson laboratory showed that Yck2p rides on secretory vesicles to reach the plasma membrane ([@B1]). This observation is consistent with a role for the Yck1p/Yck2p kinases in Sec2p phosphorylation. Given that we reported that Sec2p phosphorylation is important to ensure efficient vesicular transport ([@B35]), we investigated the extent to which Yck1p and Yck2p are important for secretion.

First, we incubated the *yck-ts* mutant for 2 h at 37°C and examined it by thin-section electron microscopy. Compared to the wild-type strain, *yck-ts* cells accumulate several (∼2.3 per cell section) Berkley bodies, aberrant Golgi-related structures not present in the control strain ([Figure 4A](#F4){ref-type="fig"}). In addition, we often observed accumulation of debris in the vacuole. We repeated the experiment after a shift of the cells for 90 min to 32°C, to be consistent with the Bgl2p secretion experiment described later, and we again observed a Berkley body phenotype, albeit to a lesser extent (Supplemental Figure S3).

![The secretory pathway is affected in the *yck-ts* strain. (A) Control yeast strain or the *yck-ts* strain (NY3109 and NY3110, respectively) were shifted at early log phase for 2 h to 37°C and processed for thin-section electron microscopy (scale bar, 1 μm). (B) Bgl2p secretion is affected in the *yck-ts* strain. Control yeast strain, the *yck-ts* mutant, and *sec6-4* strain (NY3109, NY3110, and NY17, respectively) were grown overnight at 25°C to early log phase and shifted for 1½ h to 32°C. Protein lysates from the internal and the external pool were prepared, and Bgl2p protein was detected with anti-Bgl2p antibody. The intensity of the internal Bgl2p was quantified using ImageJ and normalized (the condition WT at 32°C was set at 1) and is indicated. Mean and SD of at least three different experiments. \**p* \< 0.004; Student's *t* test.](686fig4){#F4}

Next we analyzed the secretion of the cell wall glucanase Bgl2p in the *yck-ts* mutant ([Figure 4B](#F4){ref-type="fig"}). We observed that, after incubation of yeast cells for 90 min at 32°C, the *yck-ts* mutant showed a threefold internal accumulation of Bgl2p protein compared with the wild-type strain. We used 32°C as the restrictive temperature for these experiments because the isogenic wild-type strain exhibited elevated internal levels of Bgl2p at 37°C. The *sec6-4* mutant, used as a bona fide secretory mutant control, accumulated a much greater fraction of Bgl2p in an intracellular pool. We also attempted to analyze the secretion of invertase in the *yck-ts* mutant, but since Yck1p/Yck2p are important for glucose sensing, and invertase repression requires this signaling pathway, the experiment could not be performed due to a failure to initially repress invertase synthesis.

We also analyzed Bgl2p secretion in yeast cells expressing Sec2p phosphomutants Sec2p S181-8A and D/E. However, we detected no Bgl2p accumulation (Supplemental Figure S4A). Finally, we investigated whether the phosphomimetic Sec2p mutant (S181-8D/E) is able to rescue the Bgl2p accumulation observed in the *yck-ts* mutant. However, Bgl2p accumulated to a similar extent in a *yck-ts* mutant expressing the phosphomimetic *SEC2* gene (Supplemental Figure S4B). Together these results strongly suggest that Yck1/2p has additional target(s) other than Sec2p, which act upstream on the secretory pathway.

Genetic interactions between *yck2* and components of the secretory machinery
-----------------------------------------------------------------------------

Next we examined the genetic interactions between *yck2* and different components of the secretory pathway. We generated a yeast strain deleted for *YCK2* gene (in our genetic background) and crossed it to different mutant strains affected in components involved at various stages of the secretory pathway ([Table 1](#T1){ref-type="table"}). Dissection plates and growth test results are shown in Supplemental Figures S5 and S6, respectively. *yck2Δ* exhibits strong genetic interactions with *sec2-59* and *sec15-1* alleles, as indicated by the synthetic negative effect on growth observed at all temperatures tested. This is consistent with a stimulatory role for Yck2p in the regulation of the Sec2p--Sec15p interaction. We also observed a strong negative genetic interaction with the *pik1-101* allele on the dissection plate. Milder genetic interactions were observed with *sec12-4*, *ypt31Δ-ypt32^A141D^*, *sec4-8*, *sec6-4*, *sec3-2*, *sec8-9*, *sec5-24*, *sec10-2*, and *sec1-1* alleles, since a growth defect or lethality (*sec5-24*) was observed only at 16, 30, or 33°C. No synthetic effects were observed with *sec7-1*, *sec14-3*, *gyp1Δ*, and *sec9-4* alleles. Taken together, these findings strongly suggest that the kinases Yck1/2p play an active role at one or more stages of the secretory pathway.

###### 

Genetic interactions between *yck2* and different components of the secretory pathway.

  -------------------
  ![](686ufig1.jpg)
  -------------------

^a^Variability unlinked to *yck2*.

^b^We observed a strong negative genetic interaction between *yck2* and *pik1-101* on the dissection plate (Supplemental Figure S2A). However, when single mutant (*pik1-101*) or double mutants (*pik1-101+ yck2Δ*) were tested for growth, we observed variations between colonies at all indicated temperatures.

For comparison, we examined the genetic interactions between the nonphosphorylatable *sec2* mutant and the different components of the secretory pathway. We used a yeast strain expressing *sec2 S181-8A 3xGFP* as the only copy of *SEC2*, as well as the control strain expressing *wild-type SEC2-3xGFP*, and we crossed them to the different mutant strains ([Table 2](#T2){ref-type="table"}). Dissection plates and growth test results are shown in Supplemental Figures S7 and S8, respectively. We were unable to test the interaction with *sec14-3*, *gyp1Δ*, and *sec10-2* because of the lack in our collection of a strain with the appropriate selection marker. Owing to tight linkage of *SEC2* and *PIK1*, we failed to obtain double mutants in a cross with the *pik1-101* allele. We observed a strong genetic interaction of *sec2 S181-8A* with *ypt31Δ-ypt32^A141D^* at all temperatures tested ([@B35]) and a mild genetic interaction with *sec3-2* at 16°C. However, we observed no synthetic effects with the other secretory components. These results strengthen the hypothesis that Yck1/2p has targets in addition to Sec2p on the secretory pathway.

###### 

Genetic interactions between *sec2 S181-8A 3xGFP* and different components of the secretory pathway.

  -------------------
  ![](686ufig2.jpg)
  -------------------

^a^See [@B35].

^b^Variability unlinked to *sec2 S181-8A 3xGFP*.

DISCUSSION
==========

We show here that Sec2p is subject to phosphorylation by the redundant casein kinases Yck1p and Yck2p. This modification promotes the interaction of Sec2p with the downstream effector Sec15p and contributes to Sec2p localization and function. Phosphorylation appears to be coupled to the cycle of vesicular traffic, requiring prior association of Sec2p with the vesicle and subsequent reduction of the inhibitory Golgi lipid PI(4)P from the vesicle membrane (see [Figure 5](#F5){ref-type="fig"} for a working model of the role of Yck1p/Yck2p's in Sec2p phosphoregulation). Dephosphorylation of Sec2p is a very late event in the transport reaction; however, it is not clear whether it normally occurs before or after exocytic fusion. A phosphomimetic *sec2* allele displays localization defects and synthetic genetic interactions that imply an important role for the dephosphorylated form of Sec2p ([@B35]), perhaps in recycling to newly formed vesicles. Although Sec2p is predominantly in its phosphorylated state under normal growth conditions, growth in a poor carbon source leads to reduced phosphorylation, consistent with a role for Yck1/2p in modulating the function of the secretory pathway in response to nutritional cues. Conversely, an increase in temperature leads to an increase in Sec2p phosphorylation, paralleling the increased growth rate at elevated temperatures. Finally, this study suggests that Yck1/2p not only regulates Sec2p but also has one or more additional targets on the secretory pathway that remain to be identified.

![Model for Yck1p/Yck2p's role in Sec2p phosphoregula­tion. Nonphosphorylated Sec2p is recruited to the Golgi by the recognition of both the Rab Ypt32p-GTP and the phosphoinositide PI(4)P. Once recruited to membranes, Sec2p phosphorylation by the kinases Yck1p/Yck2p, which uses the secretory pathway to reach the plasma membrane, is inhibited by the high level of PI(4)P. The Golgi-derived secretory vesicle buds off, and Sec2p activates the Rab Sec4p, which recruits its effector, Sec15p. During the transit of the vesicle to the cell surface, the PI(4)P level drops by the action of the lipid transporter Osh4p. This triggers a conformation change in Sec2p, allowing Sec15p to replace Ypt32p-GTP on Sec2p, and allows Sec2p phosphorylation by Yck1p/Yck2p, which further enhances the Sec2p--Sec15p interaction. This process pushes the reaction forward and creates a positive-feedback loop that generates a microdomain of high Sec4p-GTP and Sec15p, facilitating the delivery, tethering, and fusion of the vesicle with the plasma membrane. Before fusion, Sec2p is dephosphorylated by a yet-unknown phosphatase that allows Sec2p to dissociate from Sec15p and thus dissociate from the vesicle. The unphosphorylated Sec2p is then ready to associate with a new round of secretory vesicles and thus ensure the continuity of vesicular transport.](686fig5){#F5}

Yeast express four different members of the CK1 family: Yck1p, Yck2p, Yck3p, and Hrr25p. Yck1p and Yck2p were previously ­implicated in the regulation of endocytosis of cell surface proteins ([@B31]; [@B23]; [@B29]; [@B11]). Yck3p regulates traffic to the yeast vacuole by phosphorylating the homotypic fusion and vacuole protein sorting tethering complex and the GEF Mon1 ([@B4]; [@B45]; [@B19]), whereas Hrr25p phosphorylates the COPII coat complex directing traffic from the ER to the Golgi and also plays a key role in the regulation of autophagy ([@B22]; [@B28]; [@B32]; [@B38]; [@B42]). Our data implicating Yck1p and Yck2p in the regulation of traffic at the final stage of the secretory pathway fit well with this broad pattern in which all members of the CK1 kinase family act in the regulation of membrane traffic. Recent evidence shows that Hrr25p functions as an effector of the Rab GTPase Ypt1p ([@B42]). We considered that Yck1/2p might by analogy serve as an effector of either Ypt31/32p or Sec4p but found no evidence to support this (unpublished data).

The buildup of an internal pool of the cell wall glucanase Bgl2p in the *yck-ts* mutant is consistent with the proposed role of Yck1/2p in the function of Sec2p at the final stage of the secretory pathway. However, the accumulation of Golgi-related Berkley bodies rather than secretory vesicles implies an additional role for Yck1/2p within the Golgi, upstream of Sec2p function. We observed strong synthetic interactions between *yck2* and the Golgi phosphatidylinositol 4-kinase *pik1.* In addition, it was reported that, in the absence of glucose, Pik1p relocates from the *trans*-Golgi to the nucleus, possibly a manifestation of the role of Yck1/2p in glucose signaling. Furthermore in vitro kinase assays showed that Yck2p can phosphorylate Pik1p ([@B33]; [@B7]), and four of the known phosphosites ([www.phosphogrid.org/sites/35573](http://www.phosphogrid.org/sites/35573)) within the Pik1p sequence fit the consensus for casein kinases. Therefore it is possible that the proposed role for Yck1/2p in Golgi function reflects the phosphorylation of Pik1p by Yck1/2p. Nonetheless, the putative Golgi target of Yck1/2p has not yet been established.

Homologues of Sec2p in other species are also regulated by phosphorylation. The mammalian homologue Rabin8 is phosphorylated at a site that aligns closely with the Yck1/2p site in Sec2p, residues 181--188 (S272 present in the consensus site HxRxxS/T; [@B39]; [@B6]; Supplemental Figure S9). Phosphorylation at this site promotes interaction with the mammalian homologue of Sec15p, whereas blocking phosphorylation impairs the role of Rabin8 in ciliogenesis and dendritic spine development. Nonetheless, phosphorylation in this situation is mediated by the NDR1/2 kinase, not a casein kinase. The yeast genome encodes three homologues of the NDR kinase family: Cbk1p, Dbf2p, and Dbf20p ([@B15]). The 181--188 site does not fit the consensus for this class of kinase, which has a preference for basic amino acids ([@B24]). Furthermore, Sec2p 1-508 phosphorylation is unaffected in a drug-sensitive Cbk1 mutant (Cbk1-as) or in strains deleted for *DBF2* or *DBF20* (unpublished data). Rabin8 is phosphorylated by the ERK1/2 kinase at four sites (SP motifs; two of which, S247 and S250, are indicated in Supplemental Figure S9) that lie upstream of the region aligning with residues 181--188 in Sec2p ([@B43]). Unlike phosphorylation by NDR2 ([@B6]), phosphorylation by ERK1/2 stimulates the exchange activity of Rabin8 by relieving autoinhibition ([@B43]). Our results indicate that phosphorylation in the Sec15p/Ypt32p binding region does not affect the exchange activity of Sec2p, excluding such a mechanism, at least for these phosphosites (S181--188); instead, they are more important for the localization of Sec2p and its interaction with binding partners.

As master regulators of membrane traffic, Rab GTPases must themselves be subject to regulation. Rab GEFs represent key focal points of regulation by different signaling pathways. Whereas different pathways are used in different species and perhaps in different tissues, many of the underlying regulatory mechanisms are well conserved.

MATERIALS AND METHODS
=====================

Plasmid construction and strains
--------------------------------

Lists of *S. cerevisiae* strains and plasmids used in this study and their genotypes are given in [Table 3](#T3){ref-type="table"} and Supplemental Tables S1 and S2. All vectors generated in this study were checked by sequencing.

###### 

Yeast strains.

  Yeast name   Alias           Background/parental strain   Genotype                                                                                                                                   Source
  ------------ --------------- ---------------------------- ------------------------------------------------------------------------------------------------------------------------------------------ -------------------
  NY3099       DSY157          BY4741                       MATa, his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 \[p413 GPDp Sec2 1-508, CEN HIS\]                                                                       This study
  NY3100       DSY153          BY4741                       MATa, his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 \[Δyck3::KanMX4\] \[p413 GPDp Sec2 1-508, CEN HIS\]                                                     This study
  NY3101       DSY154          BY4741                       MATa, his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 \[Δyck1::KanMX4\] \[p413 GPDp Sec2 1-508, CEN HIS\]                                                     This study
  NY3102       DSY155          BY4741                       MATa, his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 \[Δyck2::KanMX4\] \[p413 GPDp Sec2 1-508, CEN HIS\]                                                     This study
  NY3103       DSY158          BY4741                       MATa, his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 \[p413 GPDp GST Sec2 1-508, CEN HIS\]                                                                   This study
  NY3104       DSY161          BY4741                       MATa, his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 \[Δyck3::KanMX4\] \[p413 GPDp GST Sec2 1-508, CEN HIS\]                                                 This study
  NY3105       DSY162          BY4741                       MATa, his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 \[Δyck1::KanMX4\] \[p413 GPDp GST Sec2 1-508, CEN HIS\]                                                 This study
  NY3106       DSY163          BY4741                       MATa, his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 \[Δyck2::KanMX4\] \[p413 GPDp GST Sec2 1-508, CEN HIS\]                                                 This study
  NY3107       DSY169/LRB264   LR                           MATa, his3 leu2 ura3-52 \[Δyck1::URA3\]                                                                                                    Lucy Robinson
  NY3108       DSY170/LRB265   LR                           MATα, his3 leu2 ura3-52 \[yck2-1::HIS3\]                                                                                                   Lucy Robinson
  NY3109       DSY171/LRB341   LR                           MATa, his3 leu2 ura3-52                                                                                                                    Lucy Robinson
  NY3110       DSY172/LRB345   LR                           MATa, his3 leu2 ura3-52 Δyck1 yck2-2ts                                                                                                     Lucy Robinson
  NY3111       DSY180          DSY171                       MATa, his3 leu2 ura3-52 \[p415 GPDp GST Sec2 1-508, CEN LEU\]                                                                              This study
  NY3112       DSY176          DSY169                       MATa, his3 leu2 ura3-52 \[Δyck1::URA3\] \[p415 GPDp GST Sec2 1-508, CEN LEU\]                                                              This study
  NY3113       DSY178          DSY170                       MATa, his3 leu2 ura3-52 \[yck2-1::URA3\] \[p415 GPDp GST Sec2 1-508, CEN LEU\]                                                             This study
  NY3114       DSY182          DSY172                       MATa, his3 leu2 ura3-52 Δyck1 yck2-2ts \[p415 GPDp GST Sec2 1-508, CEN LEU\]                                                               This study
  NY3115       DSY320          DSY171                       MATa, his3 leu2 ura3-52 \[p415 GPDp GST Sec2 full-length WT, CEN LEU\]                                                                     This study
  NY3116       DSY322          DSY171                       MATa, his3 leu2 ura3-52 \[p415 GPDp GST Sec2 full-length S181A + T183A + S184A + S185A + S186A + T187A + S188A, CEN LEU\]                  This study
  NY3117       DSY324          DSY171                       MATa, his3 leu2 ura3-52 \[p415 GPDp GST Sec2 full-length S181D + T183E + S184D + S185D + S186D + T187E + S188D, CEN LEU\]                  This study
  NY3118       DSY326 DSY327   DSY172                       MATa, his3 leu2 ura3-52 Δyck1 yck2-2ts \[p415 GPDp GST Sec2 full-length WT, CEN LEU\]                                                      This study
  NY3119       DSY329          DSY172                       MATa, his3 leu2 ura3-52 Δyck1 yck2-2ts \[p415 GPDp GST Sec2 full-length S181A + T183A + S184A + S185A + S186A + T187A + S188A, CEN LEU\]   This study
  NY3120       DSY331          DSY172                       MATa, his3 leu2 ura3-52 Δyck1 yck2-2ts \[p415 GPDp GST Sec2 full-length S181D + T183E + S184D + S185D + S186D + T187E + S188D, CEN LEU\]   This study
  NY3121       DSY209          DSY171                       MATa, his3 leu2 ura3-52 \[p415 GPDp GST Sec2 1-508 S181A + T183A + S184A + S185A + S186A + T187A + S188A, CEN LEU\]                        This study
  NY3122       DSY211          DSY171                       MATa, his3 leu2 ura3-52 \[p415 GPDp GST Sec2 1-508 S181D + T183E + S184D + S185D + S186D + T187E + S188D, CEN LEU\]                        This study
  NY3123       DSY213          DSY172                       MATa, his3 leu2 ura3-52 Δyck1 yck2-2ts \[p415 GPDp GST Sec2 1-508 S181A + T183A + S184A + S185A + S186A + T187A + S188A, CEN LEU\]         This study
  NY3124       DSY215          DSY172                       MATa, his3 leu2 ura3-52 Δyck1 yck2-2ts \[p415 GPDp GST Sec2 1-508 S181D + T183E + S184D + S185D + S186D + T187E + S188D, CEN LEU\]         This study
  NY3125       DSY130          NY1210                       MATa, his3-Δ200 leu2-3112 ura3-52 GAL+ \[p415 GPDp GST Sec2 1-508, CEN LEU\]                                                               This study
  NY3126       DSY348          NY3039                       MATα, his3-Δ200 leu2-3112 ura3-52 ypt31Δ::HIS3 ypt32A141D \[p415 GPDp GST Sec2 1-508, CEN LEU\]                                            This study
  NY775                                                     MATa, leu2-3112 sec4-8                                                                                                                     Laboratory strain
  NY3127       DSY240          NY775                        MATa, leu2-3112 sec4-8 \[p415 GPDp GST Sec2 1-508, CEN LEU\]                                                                               This study
  NY786                                                     MATa, leu2-3112 ura3-52 sec15-1                                                                                                            Laboratory strain
  NY3128       DSY234          NY786                        MATa, leu2-3112 ura3-52 sec15-1 \[p415 GPDp GST Sec2 1-508, CEN LEU\]                                                                      This study
  NY884                                                     MATa, leu2-3112 ura3-52 sec6-4                                                                                                             Laboratory strain
  NY3129       DSY236                                       MATa, leu2-3112 ura3-52 sec6-4 \[p415 GPDp GST Sec2 1-508, CEN LEU\]                                                                       This study
  NY769                                                     MATa, leu2-3112 sec1-1                                                                                                                     Laboratory strain
  NY3130       DSY237                                       MATa, leu2-3112 sec1-1 \[p415 GPDp GST Sec2 1-508, CEN LEU\]                                                                               This study
  NY3131       Ling060                                      MATα, his3-Δ200 leu2-3112 ura3-52 GAL+ \[Δosh4::KanMX4\]                                                                                   Laboratory strain
  NY3132       DSY442          Ling060                      MATα, his3-Δ200 leu2-3112 ura3-52 GAL+ \[Δosh4::KanMX4\] \[p415 GPDp GST Sec2 1-508, CEN LEU\]                                             This study
  NY3133       DSY441          NY2187                       MATα, leu2-3112 pik1-101 \[p415 GPDp GST Sec2 1-508, CEN LEU\]                                                                             This study
  NY3134       DSY196          DSY171                       MATa, his3 leu2 ura3-52 SEC15::\[Sec15-13xmyc URA\]                                                                                        This study
  NY3135       DSY198          DSY172                       MATa, his3 leu2 ura3-52 Δyck1 yck2-2ts SEC15::\[Sec15-13xmyc URA\]                                                                         This study
  NY3136       DSY204          DSY171                       MATa, his3 leu2 ura3-52 SEC2::\[Sec2 WT 3xGFP LEU2\] SEC15::\[Sec15-13xmyc URA\]                                                           This study
  NY3137       DSY207          DSY172                       MATa, his3 leu2 ura3-52 Δyck1 yck2-2ts SEC2::\[Sec2 WT 3xGFP LEU2\] SEC15::\[Sec15-13xmyc URA\]                                            This study
  NY1210                                                    MATa, his3-Δ200 leu2-3112 ura3-52 GAL+                                                                                                     Laboratory strain
  NY3138       DSY267          NY1210                       MATa, his3-Δ200 leu2-3112 ura3-52 GAL+ \[YEp352 GFP Yck2, 2μ URA\]                                                                         This study
  NY3139       DSY337          NY1210                       MATa, his3-Δ200 leu2-3112 ura3-52 GAL+ \[YEp352 GFP Yck2 H187Y, 2μ URA\]                                                                   This study
  NY3140       DSY245          NY1210                       MATa, his3-Δ200 leu2-3112 ura3-52 GAL+ \[Δyck2::kanMX6\]                                                                                   This study
  NY3039       MY481           NY1210                       MATα, his3-Δ200 leu2-3112 ura3-52 \[ypt31Δ::HIS3\] ypt32^A141D^                                                                            Laboratory strain
  NY3141       DSY251          NY                           His3-Δ200 leu2-3112 ura3-52 \[ypt31Δ::HIS3\] ypt32^A141D^ \[Δyck2::kanMX6\]                                                                This study
  NY787                        NY                           MATα, leu2-3112 sec15-1                                                                                                                    Laboratory strain
  NY3142       DSY263          NY                           leu2-3112 sec15-1 \[Δyck2::kanMX6\]                                                                                                        This study
  NY27                         NY                           MATα, ura3-52 sec2-59                                                                                                                      Laboratory strain
  NY3143       DSY255          NY                           ura3-52 sec2-59 \[Δyck2::kanMX6\]                                                                                                          This study
  NY774                        NY                           MATα, leu2-3112 ura3-52 sec4-8                                                                                                             Laboratory strain
  NY3144       DSY259          NY                           leu2-3112 ura3-52 sec4-8 \[Δyck2::kanMX6\]                                                                                                 This study
  NY427                        RS                           MATα, leu2-3112 ura3-52 trp1^−^ his4^−^ sec12-4                                                                                            Laboratory strain
  NY3145       DSY278          NY                           leu2-3112 ura3-52 trp1^−^ his4^−^ sec12-4 \[Δyck2::kanMX6\]                                                                                This study
  NY760                        NY                           MATα, ura3-52 sec7-1                                                                                                                       Laboratory strain
  NY3146       DSY281          NY                           ura3-52 sec7-1 \[Δyck2::kanMX6\]                                                                                                           This study
  NY778                        NY                           MATα, leu2-3112 ura3-52 sec6-4                                                                                                             Laboratory strain
  NY3147       DSY285          NY                           leu2-3112 ura3-52 sec6-4 \[Δyck2::kanMX6\]                                                                                                 This study
  NY831                        NY                           MATα, leu2-3112 ura3-52 sec9-4                                                                                                             Laboratory strain
  NY3148       DSY289                                       leu2-3112 ura3-52 sec9-4 \[Δyck2::kanMX6\]                                                                                                 This study
  NY768                        NY                           MATα, leu2-3112 ura3-52 sec1-1                                                                                                             Laboratory strain
  NY3149       DSY293                                       leu2-3112 ura3-52 sec1-1 \[Δyck2::kanMX6\]                                                                                                 This study
  NY1224                       NY                           MATα, leu2-3112 ura3-52 sec3-2                                                                                                             Laboratory strain
  NY3150       DSY296          NY                           leu2-3112 ura3-52 sec3-2 \[Δyck2::kanMX6\]                                                                                                 This study
  NY780                        NY                           MATα, leu2-3112 ura3-52 sec8-9                                                                                                             Laboratory strain
  NY3151       DSY304          NY                           leu2-3112 ura3-52 sec8-9 \[Δyck2::kanMX6\]                                                                                                 This study
  NY776                        NY                           MATα, leu2-3112 ura3-52 sec5-24                                                                                                            Laboratory strain
  NY3152       DSY300          NY                           leu2-3112 ura3-52 sec5-24 \[Δyck2::kanMX6\]                                                                                                This study
  NY63                         NY                           MATα, his4-619 sec10-2                                                                                                                     Laboratory strain
  NY3153       DSY308          NY                           his4-619 sec10-2 \[Δyck2::kanMX6\]                                                                                                         This study
  NY1420                                                    MATα, leu2-3112 sec14-3                                                                                                                    Laboratory strain
  NY3154       DSY367                                       leu2-3112 sec14-3 \[Δyck2::kanMX6\]                                                                                                        This study
  NY2331                       NY                           MATα, leu2-3112 ura3-52 ade2 ade3 his3 \[Δgyp1::LEU2\]                                                                                     Laboratory strain
  NY3155       DSY363                                       leu2-3112 ura3-52 ade2 ade3 his3 \[Δgyp1::LEU2\] \[Δyck2::kanMX6\]                                                                         This study
  NY2187                       NY                           MATα, leu2-3112 pik1-101                                                                                                                   Laboratory strain
  NY17                         NY                           MATa, ura3-52 sec6-4                                                                                                                       Laboratory strain
  NY3156       DSY184          LR                           MATa, his3 leu2 ura3-52 SEC2::\[Sec2-WT-3xGFP HIS3\]                                                                                       This study
  NY3157       DSY186/188      LR                           MATa, his3 leu2 ura3-52 Δyck1 yck2-2ts SEC2::\[Sec2-WT-3xGFP HIS3\]                                                                        This study
  NY3158       DSY316          NY3039                       MATα, his3-Δ200 leu2-3112 ura3-52 \[ypt31Δ::HIS3\] ypt32^A141D^ SEC2::\[Sec2-WT-3xGFP LEU2\]                                               This study
  NY3159       DSY319          DSY251                       His3-Δ200 leu2-3112 ura3-52 \[ypt31Δ::HIS3\] ypt32^A141D^ \[Δyck2::kanMX6\] SEC2::\[Sec2-WT-3xGFP LEU2\]                                   This study
  NY3160       DSY273          LR                           MATa, his3 leu2 ura3-52 SEC15::\[Sec15-3xGFP HIS\]                                                                                         This study
  NY3161       DSY274          LR                           MATa, his3 leu2 ura3-52 Δyck1 yck2-2ts SEC15::\[Sec15-3xGFP HIS\]                                                                          This study
  NY3162       DSY225          LR                           MATa, his3 leu2 ura3-52 URA::\[ADHp-GFP-Ypt32\]                                                                                            This study
  NY3163       DSY229          LR                           MATa, his3 leu2 ura3-52 Δyck1 yck2-2ts URA::\[ADHp-GFP-Ypt32\]                                                                             This study
  NY3164       DSY437          BY4741                       MATa, his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 \[Δsac1::KanMX4\] \[p413 GPDp Sec2 1-508, CEN HIS\]                                                     This study
  NY2911                       NY                           MATa, his3-Δ200 leu2-3112 ura3-52 SEC2::\[Sec2-WT-3xGFP LEU2\]                                                                             Laboratory strain
  NY3037                       NY                           MATa, his3-Δ200 leu2-3112 ura3-52 SEC2::\[Sec2-S181A + T183A + S184A + S185A + S186A + T187A + S188A-3xGFP LEU2\]                          Laboratory strain
  NY3165       DSY76           NY                           leu2-3112 ura3-52 sec4-8 SEC2::\[Sec2-WT-3xGFP LEU2\]                                                                                      This study
  NY3166       DSY77           NY                           leu2-3112 ura3-52 sec4-8 SEC2::\[Sec2-S181A + T183A + S184A + S185A + S186A + T187A + S188A-3xGFP LEU2\]                                   This study
  NY3167       DSY475          NY                           leu2-3112 sec15-1 SEC2::\[Sec2-WT-3xGFP LEU2\]                                                                                             This study
  NY3168       DSY476          NY                           leu2-3112 sec15-1 SEC2::\[Sec2-S181A + T183A + S184A + S185A + S186A + T187A + S188A-3xGFP LEU2\]                                          This study
  NY3169       DSY189          LR                           MATa, his3 leu2 ura3-52 SEC2::\[Sec2-WT-3xGFP LEU2\]                                                                                       This study
  NY3170       DSY471          LR                           MATa, his3 leu2 ura3-52 SEC2::\[Sec2-S181A + T183A + S184A + S185A + S186A + T187A + S188A-3xGFP LEU2\]                                    This study
  NY3171       DSY465          LR                           MATa, his3 leu2 ura3-52 SEC2::\[Sec2-S181D + T183E + S184D + S185D + S186D + T187E + S188D-3xGFP LEU2\]                                    This study
  NY3172       DSY483          NY                           leu2-3112 ura3-52 sec1-1 SEC2::\[Sec2-WT-3xGFP LEU2\]                                                                                      This study
  NY3173       DSY484          NY                           leu2-3112 ura3-52 sec1-1 SEC2::\[Sec2-S181A + T183A + S184A + S185A + S186A + T187A + S188A-3xGFP LEU2\]                                   This study
  NY3174       DSY494          NY                           leu2-3112 ura3-52 sec3-2 SEC2::\[Sec2-WT-3xGFP LEU2\]                                                                                      This study
  NY3175       DSY495          NY                           leu2-3112 ura3-52 sec3-2 SEC2::\[Sec2-S181A + T183A + S184A + S185A + S186A + T187A + S188A-3xGFP LEU2\]                                   This study
  NY3176       DSY504          NY                           leu2-3112 ura3-52 trp1^−^ his4^−^ sec12-4 SEC2::\[Sec2-WT-3xGFP LEU2\]                                                                     This study
  NY3177       DSY505          NY                           leu2-3112 ura3-52 trp1^−^ his4^−^ sec12-4 SEC2::\[Sec2-S181A + T183A + S184A + S185A + S186A + T187A + S188A-3xGFP LEU2\]                  This study
  NY3178       DSY192          LR                           MATa, his3 leu2 ura3-52 Δyck1 yck2-2ts SEC2::\[Sec2-WT-3xGFP LEU2\]                                                                        This study
  NY3179       DSY468          LR                           MATa, his3 leu2 ura3-52 Δyck1 yck2-2ts SEC2::\[Sec2-S181D + T183E + S184D + S185D + S186D + T187E + S188D-3xGFP LEU2\]                     This study
  NY3180       DSY507          NY                           leu2-3112 ura3-52 sec8-9 SEC2::\[Sec2-WT-3xGFP LEU2\]                                                                                      This study
  NY3181       DSY508          NY                           leu2-3112 ura3-52 sec8-9 SEC2::\[Sec2-S181A + T183A + S184A + S185A + S186A + T187A + S188A-3xGFP LEU2\]                                   This study
  NY3182       DSY515          NY                           leu2-3112 ura3-52 sec6-4 SEC2::\[Sec2-WT-3xGFP LEU2\]                                                                                      This study
  NY3183       DSY516          NY                           leu2-3112 ura3-52 sec6-4 SEC2::\[Sec2-S181A + T183A + S184A + S185A + S186A + T187A + S188A-3xGFP LEU2\]                                   This study
  NY3184       DSY523          NY                           leu2-3112 ura3-52 sec5-24 SEC2::\[Sec2-WT-3xGFP LEU2\]                                                                                     This study
  NY3185       DSY524          NY                           leu2-3112 ura3-52 sec5-24 SEC2::\[Sec2-S181A + T183A + S184A + S185A + S186A + T187A + S188A-3xGFP LEU2\]                                  This study
  NY3186       DSY531          NY                           leu2-3112 ura3-52 sec9-4 SEC2::\[Sec2-WT-3xGFP LEU2\]                                                                                      This study
  NY3187       DSY532          NY                           leu2-3112 ura3-52 sec9-4 SEC2::\[Sec2-S181A + T183A + S184A + S185A + S186A + T187A + S188A-3xGFP LEU2\]                                   This study

To generate the p415 GPDp GST Sec2 1-508 CEN vector (LEU) (NRB1601), the GST Sec2 1-508 fragment was excised from NRB1156 with *Pst*1 and *Hin*dIII and cloned back into NRB851.

To generate the p413 GPDp Sec2 1-508 CEN vector (HIS; NRB1599), the Sec2 1-508 fragment was excised from the p415 GPDp GST Sec2 1-508 CEN vector (NRB1601) with *Bam*H1 and *Sal*1 and cloned back into NRB847.

To generate the p413 GPDp GST Sec2 1-508 CEN vector (HIS; NRB1600), the GST Sec2 1-508 fragment was excised from the p415 GPDp GST Sec2 1-508 CEN vector (LEU; (NRB1601) with *Spe*1 and *Sal*1 and cloned back into NRB847.

To generate p415 GPDp GST Sec2 1-508 S181-8A or D/E CEN vectors (LEU; (NRB1605 and NRB1606, respectively), Sec2 fragments bearing the mutations were excised from pGEX4T1 Sec2 vectors (NRB1498 and NRB1499, respectively; described in ([@B35]) with *NsI*1 and *Nde*I and cloned back into the p415 GPDp GST Sec2 1-508 CEN vector (LEU; NRB1601).

To generate p415 GPDp GST Sec2 full-length WT, S181-A, or D/E CEN vectors (LEU; NRB1602, NRB1603, and NRB1604, respectively), GST Sec2 full-length fragments were excised from pNB529 GST Sec2 vectors (NRB1153, NRB1500, and NRB1501, respectively; described in [@B35]) with *Pst*1 and *Hin*dIII and cloned back into NRB851.

All of these vectors were transformed into yeast with different backgrounds to analyze Sec2p phosphorylation by mobility shift on SDS--PAGE.

To generate the GST-Sec2 1-508 S181-8A mutant for bacterial expression (NRB1610), Sec2 fragments bearing the mutations were excised from pGEX4T1-Sec2 vector (NRB1498; described in [@B35]) with *NsI*1 and *Nde*I and cloned back into the pGEX4T1 Sec2 1-508 vector (NRB1432). This plasmid was then expressed in *Escherichia coli*, and the protein was used for the in vitro kinase assay.

The Yep352 GFP Yck2 H187Y vector (NRB1609), used for the in vitro kinase assay, was generated by PCR-based site-directed mutagenesis of the Yep352 GFP Yck2 vector (NRB1608; a gift from the Lucy Robinson laboratory, Louisiana State University Health Sciences Center, Shreveport, LA). Yep352 GFP Yck2 WT or H187Y vectors were then transformed into yeast (NY3138 and NY3139).

To generate the pRS306 Sec15C-13xmyc-ADHt vector (NY1607), the fragment 13xmyc-ADHt was excised from pRS306-Exo70C-13xmyc-ADHt (DLP78; unpublished vector) with *Bam*H1 and *Sac*1 and was used to replace the 3xGFP-ADHt fragment in the pRS306 Sec15C-3xGFP-ADHt (NRB1308). After cloning, the deletion of one nucleotide was realized by PCR-based site-directed mutagenesis between Sec15C and 13xmyc in order to have the two sequences in the same reading frame. The plasmid was then linearized using SexA1 and transformed into yeast (NY3109 and NY3110 to generate, respectively, NY3134 and NY3135) at the *SEC15* locus. The expression of Sec15-13xmyc was verified by Western blotting with anti-myc antibody (1:1000 dilution, 9B11 mouse; Cell Signaling Technology, Danvers, MA), as well as by PCR analysis to confirm that the 13xmyc had integrated into the sole full-length copy of *SEC15* in the genome. These strains were then further transformed at the *SEC2* locus with pRS305 3xGFP-Sec2 (NRB1416) linearized with *Nsi*1. PCR analysis was performed to confirm that the 3xGFP had integrated into the sole full-length copy of *SEC2* in the genome (NY3136 and NY3137). NY3134, NY3135, NY3136, and NY3137 were then used for Sec2p--Sec15p coimmunoprecipitation assays.

To analyze Sec2p localization, the pRS303 Sec2C-3xGFP yeast integrating vector (NRB1442) was linearized using *Xba*1 and transformed into the control yeast strain or the *yck-ts* mutant at the *SEC2* locus (NY3156 and NY3157, respectively). To analyze Sec2p localization in the *ypt31Δ ypt32^A141D^* sensitized background additionally deleted or not with the *YCK2* gene, the pRS305 Sec2C-3xGFP yeast integrating vector (NRB1416) was linearized using *Nsi*1 and transformed into NY3039 or NY3141 at the *SEC2* locus (NY3158 and NY3159). To analyze Sec15p localization, the pRS303 Sec15C-3xGFP yeast integrating vector (NRB1458) was linearized using SexA1 and transformed into the control yeast strain or the *yck-ts* mutant at the *SEC15* locus (NY3160 and NY3161, respectively). To analyze Ypt32p localization, the pRS306 ADHp GFP Ypt32 yeast integrating vector (NRB1325) was linearized using *Stu*1 and transformed into the control yeast strain or the *yck-ts* mutant at the *URA3* locus (NY3162 and NY3163, respectively). The expression of all fusion proteins was confirmed by Western blot analysis.

To analyze the effect of phosphomutations in *SEC2* on Bgl2p secretion, the pRS305 Sec2C-3xGFP WT, S181-8A or D/E yeast integrating vectors (NRB1416, NRB1506, and NRB1507, respectively) were linearized using *Nsi*1 and transformed into control yeast strain and *yck-ts* mutant (NY3109 and NY3110, respectively) at the *SEC2* locus (NY3169, NY3170,NY3171, NY3178, and NY3179).

The strain deleted for the *YCK2* gene, used for the genetic interaction screen (NY3140), was generated as described in [@B21]. The deletion of the *YCK2* gene was confirmed by PCR analysis. This mutant strain was then crossed to different mutant strains affected in components of the secretory pathway.

For the genetic interaction screen with the nonphosphorylatable Sec2p mutant, the control and mutant strains (NY2911 and NY3037, respectively), both having Sec2p tagged with 3xGFP, were crossed to different mutant strains affected in components of the secretory pathway.

Sec2p mobility shift analysis
-----------------------------

Yeast cells overexpressing Sec2p (full-length or 1--508) on a CEN vector were lysed at early log phase by NaOH treatment (5-min incubation with 0.1 M NaOH and pellets were directly resuspended with sample buffer). Lysates were separated by SDS--PAGE (8%) and analyzed with anti-Sec2p polyclonal antibody (laboratory antibody, 1:1000 dilution) as the primary antibody. Horseradish peroxidase (HRP)--conjugated goat anti-rabbit immunoglobulin G (IgG; 1:10,000 dilution) was used as the secondary antibody and detected with Pierce ECL Western Blotting Substrate (Thermo Scientific, Waltham, MA).

In [Figure 1B, D, and E](#F1){ref-type="fig"}, top, Sec2p was purified from yeast as described in [@B35]. For CIP treatment, the beads were washed three times with 0.5 ml of NEB buffer 3 and incubated with CIP for 20 min at 37°C (5 μl of CIP enzyme 10,000 U/ml \[New England Biolabs, Ipswich, MA\] into 100 μl of a 50% slurry of beads). For the condition CIP and EDTA, 50 mM EDTA was added in addition to CIP. Sec2p mobility was then analyzed by SDS--PAGE (8%) with Sec2p antibody as described or directly by Coomassie brilliant blue staining after SDS--PAGE (6%).

Expression and purification of GST Sec2p from *E. coli*
-------------------------------------------------------

GST alone or the different truncated or mutated GST-Sec2 alleles in pGEX4T1 vectors (NRB1152, NRB1428, NRB1431, NRB1432, NRB1498, and NRB1499) were transformed into *E. coli* Bl21 cells. The expression and the purification of the corresponding proteins were performed as previously described ([@B35]; [@B36]). The proteins bound to glutathione--Sepharose beads were used the next day for in vitro binding experiments.

For in vitro kinase assays and nucleotide exchange assays, GST-Sec2p 1-508 or full-length WT, S181-8A, or D/E was eluted with a buffer containing 100 mM Tris, pH 8.0, 300 mM NaCl, and 20 mM glutathione. Glutathione was then removed by dialysis against 20 mM Tris, pH 7.5, 100 mM NaCl, 1 mM MgCl~2~, 1 mM dithiothreitol (DTT), and 10% glycerol. For nucleotide exchange assays, Sec2p was concentrated to ∼10 μM. Proteins were stored at −80°C. The concentration of purified protein was determined by SDS--PAGE with bovine serum albumin (BSA) as standard.

Expression and purification of hexahistidine-tagged Sec4p from *E. coli*
------------------------------------------------------------------------

NRB639 was transformed into *E. coli* Bl21 cells. Cells were grown at 37°C to an OD~600~ of 0.6 and induced using 0.1 mM isopropyl β-[d]{.smallcaps}-1-thiogalactopyranoside overnight at 16°C. The bacterial pellet was resuspended in 1× phosphate-buffered saline (PBS), 160 mM NaCl, 15 mM imidazole, pH 8, 1 mM MgCl~2~, 1 mM phenylmethylsulfonyl fluoride (PMSF), and protease inhibitors (Complete EDTA-free protease inhibitor cocktail tablets \[Roche, Indianapolis, IN\]). Cells were disrupted by sonication, and Triton X-100 was added to the suspension to a final concentration of 1%, followed by a 15-min incubation at 4°C. The suspension was then cleared by centrifugation (15,000 rpm for 30 min at 4°C). After 2 h of incubation with Ni^2+^-nitriloacetic acid resin (Qiagen, Redwood City, CA), the beads were washed with 1× PBS, 160 mM NaCl, 25 mM imidazole, pH 8, 1 mM MgCl~2~, and 0.1% Triton X-100. Hexahistidine (His~6~)-Sec4p was eluted with a buffer containing 1× PBS, 160 mM NaCl, 300 mM imidazole, and 1 mM MgCl~2~. Imidazole was then removed by an overnight dialysis against 20 mM Tris, pH 7.2, 100 mM NaCl, 1 mM MgCl~2~, 1 mM DTT, and 100 μM GDP.

To load His~6~-Sec4p with GDP, MgCl~2~ was removed by using a PD-10 column (GE Healthcare, Piscataway, NJ) and a buffer containing 50 mM Tris, pH 8, 100 mM KCl, and 1 mM DTT. Then 1 mM EDTA and 1 mM GDP were added to His~6~-Sec4p, and the reaction was incubated for 30 min at room temperature. To terminate the loading reaction, MgCl~2~ was added to a final concentration of 20 mM. The excess GDP was removed using a PD-10 column and a buffer containing 20 mM Tris, pH 7.5, 100 mM NaCl, 1 mM MgCl~2~, 10% glycerol, and 1 mM DTT. His~6~-Sec4p was directly stored at −80°C. The concentration of His~6~-Sec4p was determined by SDS--PAGE with BSA as standard.

In vitro binding assay
----------------------

Yeast cells overexpressing GFP-Yck2p (NY3138) were resuspended in lysis buffer containing 1× PBS, 1 mM MgCl~2~, 1 mM PMSF, protease inhibitors (Complete EDTA-free protease inhibitor cocktail tablets), and 5 mM DTT. Cells were disrupted in a bead beater using 0.5-mm zirconia/silica beads. Triton X-100 was added to the lysate to a final concentration of 1%, followed by a 15-min incubation at 4°C and finally clearance by centrifugation at 13,000 rpm for 20 min.

One hundred OD~595~ units of yeast lysate were incubated with 0.2 μM GST-Sec2p protein purified from bacteria and immobilized on glutathione--Sepharose beads. After 2 h of incubation at 4°C, the beads were washed quickly three times with 1 ml of a buffer containing 1× PBS, 5 mM MgCl~2~, 0.05% Triton X-100, and 1 mM DTT. Bound products were separated by SDS--PAGE and analyzed with anti-GFP monoclonal antibody (1:1000 dilution; sc-9996; Santa Cruz Biotechnology, Santa Cruz, CA) as the primary antibody. The amount of GST-Sec2p in the reaction was verified by Western blotting with anti-GST antibody (1:1000 dilution; sc-459; Santa Cruz Biotechnology). HRP-conjugated goat anti-mouse and anti-rabbit IgG (1:10,000 dilution) were used, respectively, as the secondary antibodies and detected with Pierce ECL Western Blotting Substrate.

Liposome preparation
--------------------

1-Palmitoyl-2-oleoyl-*sn*-glycero-3-phospho-[l]{.smallcaps}-serine (POPS), 1,2-dipalmitoyl-*sn*-glycero-3-phosphoethanolamine (DPPE), 1,2-dipalmitoyl-*sn*-glycero-3-phosphocholine (DPPC), and brain L-α-PI(4)P) were from Avanti Polar Lipids (Alabaster, AL). All liposomes contained 20 mol% DPPE and 30 mol% POPS, with or without 2, 5, or 10 mol% PI(4)P, and the remaining lipid was DPPC. Lipids in chloroform were mixed in a pear-shaped glass container. The glass container was attached to a rotary evaporator and immersed in a water bath at 33°C for 5 min before evaporation. A lipid film was produced by rapid evaporation of chloroform under vacuum. The lipid film was resuspended in 50 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) and 120 mM KAc, pH 7.2 (4 mM lipids). The resuspension was submitted to five cycles of freezing and thawing and extruded through a polycarbonate filter with a pore size of 0.1 μm.

In vitro kinase assay
---------------------

Yeast lysates overexpressing GFP-Yck2p WT (NY3138) or H187Y (NY3139) were prepared as described for the in vitro binding assay, except that the lysis buffer was the following: 50 mM Tris, pH 7.5, 150 mM NaCl, 1 mM MgCl~2~, 1 mM PMSF, and protease inhibitors (Complete EDTA-free protease inhibitor cocktail tablets).

A 2-mg amount of lysates (in a final volume of 1 ml of lysis buffer) was precleared with 10 μl of protein A/G beads (Thermo Scientific) for 45 min at 4°C. GFP-Yck2p was immunoprecipitated for 2 h at 4°C with anti-GFP polyclonal antibody (gift from the Ferro-Novick lab). A 20-μl of protein A/G beads was added and incubated for 1½ h at 4°C. Beads were washed three times with 1 ml of lysis buffer and twice with 1 ml of kinase assay buffer containing 50 mM HEPES, pH 7.4, 5 mM MgCl~2~, and 1 mM DTT. Beads were incubated in a final volume of 30 μl of kinase assay buffer complemented with 2 μg of eluted bacterial GST-Sec2p 1-508 WT or S181-8A (0.81 μM) with or without 0.81 mM liposomes. After 5 min of incubation at 37°C, 5 mM ATP was added or not, and the reaction was incubated for an additional 1 h at 37°C.

Samples were separated by SDS--PAGE (8%), and GST Sec2p 1-508 phosphorylation was analyzed with anti-GST antibody (1:1000 dilution; sc-459; Santa Cruz Biotechnology), and GFP-Yck2p amount with anti-GFP monoclonal antibody (1:1000 dilution; sc-9996; Santa Cruz Biotechnology). HRP-conjugated goat anti-rabbit and anti-mouse IgG (1:10,000 dilution) were used, respectively, as the secondary antibodies and detected with Pierce ECL Western Blotting Substrate.

Sec2p--Sec15p coimmunoprecipitation assay
-----------------------------------------

Yeast cells were grown overnight to early log phase in yeast extract/peptone/dextrose (YPD) medium at 25°C and shifted for 1 h to 37°C (NY3134, NY3135, NY3136, and NY3137). The Sec2p--Sec15p coimmunoprecipitation assay was performed as described in [@B36], except that the lysis buffer was complemented with phosphatase inhibitors (PhosSTOP tablets \[Roche\]) and that the incubation of the lysates with anti-GFP antibody was performed for 2 h instead of overnight.

Nucleotide exchange assays
--------------------------

Nucleotide exchange on His~6~-Sec4p was monitored by following the fluorescence signal created by a FRET interaction between His~6~-Sec4p and a fluorescent analogue of GTP, mant-GTP (AnaSpec, Fremont, CA). Experiments were performed at 15°C in a buffer containing 50 mM HEPES, pH 7.2, 120 mM potassium acetate, 1 mM MgCl~2~, and 1 mM DTT (final volume of 500 μl). Fluorescence emission was monitored by using a fluorimeter (Fluorolog \[Horiba Scientific, Edison, NJ\]) with the following settings: excitation, 290 nm; emission, 460 nm; intermediate slit, 2 nm. At 60 s, 1 μM of GDP-loaded full-length His~6~-Sec4p protein was added to the reaction; at 120 s, 40 μM mant-GTP; and at 180 s, 20 or 100 nM full-length GST-Sec2p WT, S181-A, or S181-8D/E.

Growth test
-----------

Cells were grown overnight in YPD medium at 25°C. Cells were diluted to an OD~600~ of 0.04 and spotted in fivefold serial dilution on YPD plates, which were incubated at different temperatures.

Bgl2p secretion assay
---------------------

Control, *yck-ts* mutant, and *sec6-4* yeast strains (NY3109, NY3110, and NY17, respectively) were grown overnight to early log phase at 25°C in YPD medium and shifted for 1½ h at 32°C. Five OD~600~ units were collected and washed with 10 mM NaN~3~ and 1.2 M sorbitol. After 10 min of incubation on ice, cells were resuspended with 1% 2-mercaptoethanol in 50 mM Tris, pH 8.0, and 10 mM NaN~3~ and incubated for another 15 min on ice. Cells were spheroplasted with 1 ml of potassium phosphate buffer (pH 7.5) containing 1.2 M sorbitol, 1 mM MgCl~2~, 10 mM NaN~3~, and 150 μg/ml Zymolyase 100T (Nacalai Tesque, San Diego, CA) for 45 min at 37°C with gentle shaking. Spheroplasts were then pelleted at 5000 g for 10 min, and 100 μl of the supernatant (external pool) was mixed with 20 μl of 4× SDS sample buffer. The pellet (internal pool) was resuspended in 100 μl of 2× SDS sample buffer. A 2.5% amount of the internal pool and 0.25% of the external pool were separated by SDS--PAGE (12%) and analyzed by Western blotting with anti-Bgl2p antibody (1:10,000 dilution; a gift from the laboratory of Randy Schekman, University of California, Berkeley, CA). HRP-conjugated goat anti-rabbit IgG (1:10,000 dilution) was used as the secondary antibody and was detected with Pierce ECL Western Blotting Substrate.

Fluorescence microscopy
-----------------------

GFP visualization was performed as described in [@B35].

Electron microscopy
-------------------

WT and *yck-ts* mutant strains (NY3109 and NY3110, respectively) were grown overnight to early log phase at 25°C in YPD medium, shifted for 2 h at 37°C, and processed for electron microscopy as described by [@B5], except that samples were embedded in a Durcupan resin instead of a Spurr resin.
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ER

:   endoplasmic reticulum

GEF

:   guanine nucleotide exchange factor

GFP

:   green fluorescent protein

PI(4)P

:   phosphatidylinositol-4-phosphate

SNARE

:   soluble *N*-ethylmaleimide--sensitive factor attachment protein receptor
